BRPI0717458A2 - Utilização cosmética por via oral e/ou parenteral da glicosamina e da associação da glicosamina e pelo menos um composto polifenol, processo cosmético, composição para administração oral, e, complemento alimentar ou alimento funcional. - Google Patents

Utilização cosmética por via oral e/ou parenteral da glicosamina e da associação da glicosamina e pelo menos um composto polifenol, processo cosmético, composição para administração oral, e, complemento alimentar ou alimento funcional.

Info

Publication number
BRPI0717458A2
BRPI0717458A2 BRPI0717458-6A2A BRPI0717458A BRPI0717458A2 BR PI0717458 A2 BRPI0717458 A2 BR PI0717458A2 BR PI0717458 A BRPI0717458 A BR PI0717458A BR PI0717458 A2 BRPI0717458 A2 BR PI0717458A2
Authority
BR
Brazil
Prior art keywords
oral
food
cosmetic
glicosamine
glycosamine
Prior art date
Application number
BRPI0717458-6A2A
Other languages
English (en)
Inventor
Antoine Piccirilli
Patricia Manissier
Christiane Montastier
Original Assignee
Inneov Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0654425A external-priority patent/FR2907335B1/fr
Priority claimed from FR0654426A external-priority patent/FR2907339B1/fr
Application filed by Inneov Lab filed Critical Inneov Lab
Publication of BRPI0717458A2 publication Critical patent/BRPI0717458A2/pt
Publication of BRPI0717458A8 publication Critical patent/BRPI0717458A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0717458A 2006-10-20 2007-10-19 Utilização cosmética por via oral e/ou parenteral da glicosamina e da associação da glicosamina e pelo menos um composto polifenol, processo cosmético, composição para administração oral, e, complemento alimentar ou alimento funcional BRPI0717458A8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0654425A FR2907335B1 (fr) 2006-10-20 2006-10-20 Utilisation cosmetique par voie orale et/ou parenterale de la glucosamine.
FR0654426A FR2907339B1 (fr) 2006-10-20 2006-10-20 Composition comprenant de la glucosamine et au moins un polyphenol.
PCT/FR2007/052202 WO2008047061A2 (fr) 2006-10-20 2007-10-19 Utilisation cosmetique par voie orale et/ou parenterale de la glucosamine eventuellement associee a au moins un compose polyphenol et composition correspondante

Publications (2)

Publication Number Publication Date
BRPI0717458A2 true BRPI0717458A2 (pt) 2013-12-24
BRPI0717458A8 BRPI0717458A8 (pt) 2017-06-06

Family

ID=39301770

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0717458A BRPI0717458A8 (pt) 2006-10-20 2007-10-19 Utilização cosmética por via oral e/ou parenteral da glicosamina e da associação da glicosamina e pelo menos um composto polifenol, processo cosmético, composição para administração oral, e, complemento alimentar ou alimento funcional

Country Status (5)

Country Link
US (1) US20100323984A1 (pt)
EP (1) EP2079460B1 (pt)
JP (1) JP2010506893A (pt)
BR (1) BRPI0717458A8 (pt)
WO (1) WO2008047061A2 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT104241B (pt) * 2008-10-29 2012-03-06 Stargate Produtos Farmaceuticos Dieteticos E Nutricionais Lda Composições incorporando agentes redutores da celulite e inestetismos associados e formulações que as contêm
JP2010215532A (ja) * 2009-03-13 2010-09-30 Ands Corporation コラーゲンゲル収縮促進剤
FR2950884B1 (fr) * 2009-10-01 2011-11-11 Oreal Utilisation de derives de vanilline comme conservateur, procede de conservation, composes et composition
CA2809847A1 (en) * 2010-09-01 2012-03-08 The Regents Of The University Of California Cell culture screen for agents that control adipogenesis and myofibroblast differentiation
KR101886342B1 (ko) * 2010-11-30 2018-08-10 (주)아모레퍼시픽 피부 노화와 관련된 유전자 및 피부 노화를 방지하는 물질을 스크리닝하는 방법
WO2014082042A2 (en) 2012-11-25 2014-05-30 The Regents Of The University Of California Peptides that stimulate subcutaneous adipogenesis
FR3001633B1 (fr) * 2013-02-04 2017-02-24 Laboratoires Inneov Combinaison cosmetique d'actifs nutritionnels pour maintenir un bon etat esthethique de la peau et favoriser une perte de poids
WO2015184125A1 (en) 2014-05-28 2015-12-03 The Regents Of The University Of California Peptides, compositions, and methods for stimulating subcutaneous adipogenesis
CA2953260C (fr) * 2014-06-30 2020-09-15 Nutricos Technologies Produits de combinaison et compositions cosmetiques pour lutter contre les desordres de la peau et son vieillissement affectant les keratinocytes et/ou les fibroblastes et le derme
JP6799365B2 (ja) * 2015-02-26 2020-12-16 株式会社東洋新薬 化粧用組成物、美容組成物、関節保護組成物、組成物
JP7190248B2 (ja) * 2016-06-08 2022-12-15 ポーラ化成工業株式会社 皮膚支帯改善剤

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804594A (en) * 1997-01-22 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for improving wrinkles and other skin conditions
BR9908870A (pt) * 1998-03-16 2000-11-21 Procter & Gamble Processos para regularizarem a aparência da pele
FR2790645B1 (fr) * 1999-03-12 2001-06-08 Arkopharma Laboratoires Complement alimentaire et procede de traitement cosmetique a base d' un extrait de raisin riche en polyphenols
US6333304B1 (en) * 1999-04-20 2001-12-25 Teresa K. Bath Therapeutic compositions containing glucosamine, collagen and a bioflavanol for repair and maintenance of connective tissue
JP4249853B2 (ja) * 1999-08-09 2009-04-08 焼津水産化学工業株式会社 経口用皮膚潤い改善剤
AU6918700A (en) * 1999-08-20 2001-03-19 Howard Murad Pharmaceutical compositions and methods for reducing the appearance of cellulite
JP2003523395A (ja) * 2000-02-23 2003-08-05 ザ プロクター アンド ギャンブル カンパニー 経口投与に好適な組成物、並びに哺乳類の皮膚に水分を補給するためのそれらのキット及び方法
WO2004041199A2 (en) * 2002-11-01 2004-05-21 Cargill, Incorporated N-acetyl-d-glucosamine (nag) supplemented food products and beverages
EP1411783A2 (en) * 2001-04-09 2004-04-28 George Frederick Enslin A smoker's requisite
US6713096B2 (en) * 2002-01-04 2004-03-30 Melaleuca, Inc. Dietary supplements and methods for treating pain and inflammation
JP2004083432A (ja) * 2002-08-23 2004-03-18 Rohto Pharmaceut Co Ltd エラスターゼ阻害剤
JP2004083434A (ja) * 2002-08-23 2004-03-18 Rohto Pharmaceut Co Ltd コラーゲン合成促進剤
FR2861594B1 (fr) * 2003-11-03 2006-01-20 Baudry Jacquet Composition contenant un extrait de the vert et de la vitamine c
ES2998457T3 (en) * 2003-11-21 2025-02-20 Nestle Sa Food composition comprising glucosamine
WO2005089803A2 (en) * 2004-03-24 2005-09-29 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment of skin diseases comprising a combination of epinastine and one or more additional minerals or one or more crude drugs
JP4700313B2 (ja) * 2004-09-27 2011-06-15 サントリーホールディングス株式会社 プロアントシアニジン及びスフィンゴ脂質を含む組成物
US20060105989A1 (en) * 2004-11-18 2006-05-18 Kinya Takagaki Food for improving arthritis
EP2001561A2 (en) * 2006-03-31 2008-12-17 DSMIP Assets B.V. Novel use of compounds and combinations of compunds for improving the physical appearance

Also Published As

Publication number Publication date
EP2079460A2 (fr) 2009-07-22
JP2010506893A (ja) 2010-03-04
EP2079460B1 (fr) 2018-11-21
US20100323984A1 (en) 2010-12-23
WO2008047061A3 (fr) 2008-07-03
BRPI0717458A8 (pt) 2017-06-06
WO2008047061A2 (fr) 2008-04-24

Similar Documents

Publication Publication Date Title
BRPI0717458A2 (pt) Utilização cosmética por via oral e/ou parenteral da glicosamina e da associação da glicosamina e pelo menos um composto polifenol, processo cosmético, composição para administração oral, e, complemento alimentar ou alimento funcional.
BRPI0821299A2 (pt) Composto, processo para preparar o mesmo, composição farmacêutica, processo para preparar a mesma, uso de um composto, e, método para tratar, ou reduzir o risco de, uma doença ou condição.
CL2007003244A1 (es) Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
BRPI0717753A2 (pt) Método de tratamento ou redução do risco de uma doença causada por protozoários, e, composição.
BRPI0915084A2 (pt) composto, processo para a preparação de um composto, composição farmacêutica, uso de um composto, métodos para a profilaxia ou tratamento de um estado de doença ou uma condição e de câncer
BRPI0811712A2 (pt) "composto, processo de preparação de um composto e composição farmacéutica".
WO2006102610A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
CL2007003049A1 (es) Compuestos derivados de 2,4-diaminopirimidina; composicion farmaceutica, utiles para tratar trastornos proliferativos.
BRPI0717822A2 (pt) Composto, processo de fabricação de composto da fórmula i, composição farmacêutica, método de tratamento e/ou profilaxia de doenças que são associadas à modulação de receptores de cb2 e uso de composto.
BRPI0909768A2 (pt) composto, composição farmacêutica, método para o tratamento ou prevenção de uma doença ou distúrbio mediados pela ativação de b3-adrenoceptor, e, uso de um composto""composto, composição farmacêutica, método para o tratamento ou orevenção de uma doença ou distúrbio mediados pela ativação de b3-adrenoceptor, e, uso de um composto
BRPI0807807A2 (pt) " composição farmacêutica de liberação modificada e um processo para fabricar a mesma ".
BRPI0816814A2 (pt) composto, composição farmacêutica, método para tratar, prevenir ou melhorar uma doença mediada por gsk-3, uso de um composto, e, artigo de fabricação.
WO2007109192A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
BRPI0815057A2 (pt) Composto, composição farmacêutica, e, método para tratar infecção.
WO2007109172A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
CL2007003341A1 (es) Compuestos derivados de imidazotriazinas; composicion farmaceutica, util para el tratamiento del cancer, arteroesclerosis y enfermedades cardiovasculares entre otras.
ATE488517T1 (de) 3 -amino- imidazo ä1,2-aüpyridinderivate mit sglt1 und sglt2 hemmender wirkung zur behandlung von diabetes vom typ 1 und typ 2
CL2007003495A1 (es) Compuestos derivados de heterociclos condensados sustituidos, inhibidores de la actividad de la akt; composicion farmaceutica; y uso para el tratamiento o prevencion del cancer.
WO2007109160A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
BRPI0818533A2 (pt) composto, composição farmacêutica, e, processo para a preparação de um composto
WO2007109154A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
CL2007002920A1 (es) Compuestos derivados de 2-aminocarbonilpiridina; composicion farmaceutica; y uso para el tratamiento de trastornos vasculares oclusivos.
BRPI0815591A2 (pt) Composto, composição farmacêutica, uso de um composto, e, método para tratar uma doença, condição ou distúrbio.
WO2007109182A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
WO2007109201A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof

Legal Events

Date Code Title Description
B25F Entry of change of name and/or headquarter and transfer of application, patent and certif. of addition of invention: change of name on requirement

Owner name: LABORATOIRES INNEOV (FR)

B25D Requested change of name of applicant approved

Owner name: NUTRICOS TECHNOLOGIES (FR)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL